Skip to main content
. 2011 Jan 19;15(1):R32. doi: 10.1186/cc9979

Table 2.

Patient demographics characteristics (three-day ICU)

All N = 444 Non-ICU N = 333 ICU N = 111 P-value Survivors N = 351 Non-survivors N = 93 P-value
Demographics
 - Smoking 191 (43.0) 142 (42.6) 49 (44.1) 0.782 135 (38.5) 56 (60.2) <0.001
 - Male 326 (73.6) 243 (73.2) 83 (74.8) 0.743 252 (72.0) 74 (79.6) 0.141
 - Age, yrs 72.1 (15.1) 72 (15.6) 72.5 (13.6) 0.736 71.7 (15.3) 73.7 (14.1) 0.291
 - Age ≥ 65 yrs 332 (74.8) 242 (72.7) 90 (81.1) 0.077 260 (74.1) 72 (77.4) 0.509
 - Age ≥ 75 yrs 235 (52.9) 171 (51.4) 64 (57.7) 0.249 182 (51.9) 53 (57.0) 0.377
Comorbidity
 - Charlson comorbidity score 2 (1 to 3) 2 (1 to 2) 2 (1 to 3) 0.013 2 (1 to 2) 2 (2 to 3) <0.001
 - Neoplastic disease 166 (37.4) 131 (39.3) 35 (31.5) 0.141 108 (30.8) 58 (62.4) <0.001
 - Liver disease 28 (6.3) 16 (4.8) 12 (10.8) 0.024 21 (6.0) 7 (7.5) 0.586
 - Cardiovascular disease 68 (15.3) 43 (12.9) 25 (22.5) 0.015 52 (14.8) 16 (17.2) 0.569
 - Cerebrovascular disorders 120 (27.0) 81 (24.3) 39 (35.1) 0.026 100 (28.5) 20 (21.5) 0.177
 - CNS 67 (15.1) 56 (16.8) 11 (9.9) 0.078 57 (16.2) 10 (10.8) 0.189
 - Renal disease 81 (18.2) 51 (15.3) 30 (27.0) 0.006 67 (19.1) 14 (15.1) 0.370
 - Pulmonary disease 114 (25.7) 82 (24.6) 32 (28.8) 0.380 88 (25.1) 26 (28.0) 0.571
 - Diabetes mellitus 130 (29.3) 89 (26.7) 41 (36.9) 0.041 103 (29.3) 27 (29.0) 0.953
 - Immunocompromised status 54 (12.2) 38 (11.4) 16 (14.4) 0.402 43 (12.3) 11 (11.8) 0.912

*Data are expressed as number count (percentage) or median (interquartile range)